Phenylketonuria (PKU) is a metabolic genetic disorder, most well-known for the accumulation of phenylalanine, an amino acid, due to an enzyme deficiency.
Mechanism of PKU:
- The enzyme phenylalanine hydroxylase is crucial for converting phenylalanine into tyrosine.
- Mutations in the gene for this enzyme reduce its activity, leading to an overabundance of phenylalanine in the blood.
- Excess phenylalanine is harmful, particularly affecting the brain and nervous system development.
Untreated PKU can result in severe consequences such as:
- Intellectual Disabilities: High levels of phenylalanine can lead to brain damage and cognitive impairments.
- Developmental Delays: Individuals may experience delayed milestones in development.
- Behavioral Problems: Including hyperactivity and social challenges.
Newborn screening allows for early detection, enabling interventions such as low-phenylalanine diets to prevent complications. PKU demonstrates how crucial metabolic enzymes are in regulating amino acid levels and maintaining neurological health.